Summary. The effect of glucan on Leishmania major infection was studied in BALB/c mice, which are highly susceptible to leishmania infection. Glucan (0.45 mg), or isovolumetric dextrose, was administered intraperitoneally 7, 5, 3 and 1 day before infection with L. major promastigotes. At 3, 5, 6, 8 and 10 weeks after infection, animals were killed; the liver and spleen of each animal were weighed and the parasite burden was calculated. A significant (p < 0.01) reduction in amastigote proliferation in liver and spleen of animals pretreated with glucan was demonstrated 4,6 and 8 weeks after infection.
Introduction
Leishmania are protozoan parasites that infect mammalian macrophages. Leishmania tropica, L. major and L. mexicana cause a localised or diffuse skin ulcer whereas L. donouani and L. infantum cause visceral infection of the reticulo-endothelial system (Manson-Bahr, 1961 ; Zuckerman and Lainson, 1977) . Glucan, a 8-1-3 polyglucose derived from the cell wall of Saccharomyces cerevisiae is an immunamodifier that causes a dose-dependent hypertrophy and hyperplasia of reticulo-endothelial macrophages (Di Luzio, 1967; Burgaleta and Golde, 1978) . Glucan-activated macrophages kill micro-organisms in uitro and in uiuo. Moreover, glucan significantly inhibits mortality and other sequelae of infection in mice challenged with Staphylococcus aureus , Mycobacterium leprae (Delville and Jacques, 1977) , Cundida albicans (Williams et ul., 1978) , hepatitis viruses (Williams and Di Luzio, 1980) , and Plasmodium berghei (Holbrook et al., 1981) . Glucan can also enhance the non-specific and specific resistance of mice against systemic infection with L. donouani (Cook et al., 1980 and 1982) . However, Avila et al. (1982) reported that glucan failed to modify non-specific immunity to cutaneous infections with L. mexicana, L. braziziensis and L. garnhami, suggesting possible species differences in response.
We have studied the effect of glucan administration on visceralisation of L. major in spleen and liver of highly susceptible BALB/c mice, after subcutaneous inoculation of promastigotes.
Hospital, Riyadh, Saudi Arabia, and maintained in vitro and in vivo in this laboratory as described earlier (Mahmoud et al., 1985) . Inbred BALB/c male mice weighing 20-25 g were kept in air-conditioned quarters with food and water provided ad libitum. At the start of each infection the mice were 6-8 weeks old.
Treatment and infection
Glucan, kindly provided by N. R. Di Luzio (Tulane University), was prepared by a modification of the method of Hassid et al. (1941) described by Di Luzio et al. (1979) . Each mouse was given intraperitoneal injections of 0-45mg of glucan 7, 5, 3 and 1 day before parasitic infection. Control groups received isovolumetric injections of sterile dextrose 5% solution.
Promastigotes of L. major cultured in Novy, MacNeal and Nicolle's (NNN) medium as described by Mahmoud et al. (1985) were harvested, concentrated by centrifugation at 900 rpm for 30 min, suspended in 15 ml of the fluid phase of the medium and counted by microscopy in a haemocytometer. Each mouse treated with glucan or dextrose was given a subcutaneous injection of 5 x lo7 promastigotes. Five mice from each group were killed at 3, 5, 6, 8 and 10 weeks after infection. Spleen and liver weights were recorded at each interval. Liver and spleen impression slides were fixed with methanol and stained with Giemsa's stain. The parasite burden was estimated by the method of Stauber (1955) ; the number of amastigotes per 500 cell nuclei in each organ was counted and the total parasite burden (TPO) was calculated according to the following formula :
where P is the number of amastigotes, N is the number of cell nuclei and OW is the organ weight in mg. 
Results
There were no significant differences in liver or spleen weights of mice pretreated with glucan or dextrose up to 6 weeks after challenge with L. major. However, a significant difference in spleen weights between the two groups was observed 8 weeks after infection (p < 0.001) and in the weights of livers 10 weeks after infection
The parasite burdens of the glucan and dextrose treated mice differed 4, 6 and 8 weeks after infection (table) .
Whereas amastigotes were seen in spleens of the control (dextrose treated) mice during the fourth week, they were not seen in spleens of mice receiving glucan until the sixth week after infection. The parasite burden in the spleens of the control group increased sharply during the fourth week to a peak of (33-22k9.3) x lo6 amastigotes per organ, after which it gradually declined to (6.8_+ 15.3) x lo6 amastigotes by the end of week 10. The splenic parasite count in mice treated with glucan was significantly lower than in control mice 6 and 8 weeks after infection (p < 0.01 and p < 0.001 respectively), but not at week 10. The mean parasite count in the liver showed a similar pattern; there was a significantly lower (p < 0.01) parasite count in glucan treated mice 4, 6 and 8 weeks after infection, but no significant difference at the tenth week.
(p<O.Ol).
Discussion
L. major, which causes human cutaneous leishmaniasis in Saudi Arabia, usually proliferates in the spleen and liver when injected into BALB/c mice (Nasseri and Modabber, 1979; Leclerc et al., 1981 and 1982) . The finding that glucan initially suppressed proliferation of L. major in the spleen and liver of mice is in agreement with the results obtained by Cook et al. (1980 and 1982) with L. donovani. They suggested that non-specific activation of fixed macrophage populations in spleen and liver enhances killing or inhibits multiplication of the parasites. Failure to detect inhibition 10 weeks after infection may be due to a loss of glucan potency (Di Luzio, 1976) . The lack of protection by glucan against other species of Leishmania that cause infection in man, e.g., L. braziliensis may be related to the restricted localisation of the parasites in cutaneous infection (Avila et al., 1982) .
Lysozyme and peroxidase may play an important role in the mechanism of killing of Leishmania spp. (Bray, 1982; Alexander, 198 1) and Trypanosoma cruzi within phagosomes (Nathan et al., 1979) . Immunostimulants such as glucan markedly increase lysozyme levels in experimental animals (Kokoshis and Di Luzio, 1979) and we have shown that leishmania infection causes a significant decrease in serum lysozyme (A1 Mofleh et al., 1986) . The reduction in L. major amastigote proliferation by glucan could therefore be due, in part, to the release of increased amounts of intracellular lysozyme. 
